MedPath

Post-market surveillance study of the Presbia Flexivue Microlens for improvement of near vision in patients with presbyopia

Not Applicable
Conditions
Presbyopia
Registration Number
DRKS00031214
Lead Sponsor
niversitätsklinikum Frankfurt der Goethe-Universität Frankfurt
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
22
Inclusion Criteria

1. low ametropic presbyopic subjects with addition between +1.5 D and +3.5 D
2. preoperative spherical equivalent of +1.0 D to -0.75 D simultaneously cyl. <0.75 D
3. stable refraction before microlens implantation (no change of MRSE over 0.5 D in the last 6 months)
4. UNVA <20/50 (0.4 logMAR)
5. BCDVA >20/25
6. Monovision tolerance

Exclusion Criteria

1. Glaucoma, IOP >21mmHg
2. corneal thickness <480µm
3. pathology in the anterior ocular segment
4. corneal diseases
5. subjects with active or recurrent infection of eye or eyelids
6. subjects with chronic dry eye and resistance to therapy
7. subjects with irregular topography
8. subjects with retinal pathologies that affect visual rehabilitation
9. subjects with herpes zoster/simplex in past
10. steroid responders
11. subjects with uncontrolled diabetes or diabetic retinal changes
12. subjects with chronic systemic or topical corticosteroids and immunosuppressive therapie that would affect wound healing

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in uncorrected near and intermediate visual acuity
Secondary Outcome Measures
NameTimeMethod
Complication rate, Change in endothelial cell number
© Copyright 2025. All Rights Reserved by MedPath